<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

TCL Archive

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

Avoiding Mediastinal Radiation Can Improve Patient Outcomes

Obese Men With Benign Biopsy At High Risk for Prostate Cancer

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

Study Finds That CTC Was Used Correctly In Medicare Patients

ASCO Draft Recommendations Define Meaningful Trial Outcomes

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

Alcohol Consumption Does Not Impact Survival of Breast Cancer

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

European Treatment Regimen Less Toxic Than American Method